11. October 2019 - 12:15 till 13:45
Share it on:

Hear the FDA’s view on: Realizing the Promise of Regenerative Medicine: Cell and Gene-based Therapies and Beyond | Communicore Building | Friday, 11. October 2019

Realizing the Promise of Regenerative Medicine: Cell and Gene-based Therapies and Beyond

Topics of Discussion:    • Advances in regenerative medicine clinical trials    • FDA programs to accelerate the evaluation of regenerative medicine therapies    • Cell- and gene-based biologics, tissue engineering, microbiome and secretome
Can’t attend **** to ****? You don’t have to miss it. Choose to Livestream the event instead when you register.

Friday, October 11, 201912:15 - 1:45 PMCommunicore Building Room C1-15SW Archer Rd, Gainesville, FL

Speaker: Peter Marks M.D., Ph.D., Director, FDA Center for Biologics Evaluation and Research (CBER)
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.